Dr. Craig A. Craig’s Journey to the Top of Medicine
The story of Dr. Dr. Larry B. Craig, a founding member of the U.S. National Institutes of Health (NIH) and a fellow of the American College of Surgeons (ACS), began in 1966, when his father, Charles Craig, was diagnosed with amyotrophic lateral sclerosis (ALS).
Dr. Charles Craig’s disease, known as ALS, caused his limbs to lose function.
Over the next four decades, Charles and his wife, Judy, devoted their lives to research into the cause and treatment of ALS.
In 1970, Dr. William Craig, the former head of the Mayo Clinic, founded the Mayo Research Institute, which developed the first clinical trials for the treatment of the disease.
As the disease progressed, Drs.
Craig and Craig saw a growing need for a more accurate way to measure the effectiveness of the treatments being developed, and the ALS community was a natural fit.
In 1978, they launched the ALS Registry, an effort to provide more information on ALS patients and researchers.
In the 1980s, Dr Craig began a three-year research fellowship at the Cleveland Clinic, where he developed a novel, noninvasive method for measuring the effectiveness and safety of multiple ALS drugs in animal studies.
This led to the development of a standard instrument that allows for accurate diagnosis and treatment data.
Dr Craig was honored as a Fellow of the ACS in 2013.
The Institute of Medicine recently announced that Dr. Robert C. Lerman, Jr., who was appointed in the role of President of the National Institutes, will become the next chair of the Institute of Neurological Disorders and Stroke (NINDS), replacing James E. Miller.
The NINDS is an independent, nonpartisan research agency that conducts research on the causes, treatments, and future of neurological disorders.
Dr Miller was named President of NINTS in April 2018.
The President will serve until the NINSD’s full term ends in 2020.
Dr James B. Dolan, Jr. has served as the Institute’s Director of NIH’s National Institute of Health since June 2018.
Before joining NINHS, Dr Dolan served as a Professor of Medicine at Stanford University and was the director of the Stanford Center for Neurosciences from 1997 to 2000.
Prior to joining Stanford, Dr B. Scott Fitzgerald was a Professor and Head of the Department of Neurology at Harvard Medical School and was on the faculty of Harvard Medical Schools Division of Neuroscience and the Harvard Medical College Division of Neurologic Sciences from 1993 to 1997.
Dr Bostrom has been a visiting professor at the University of Oxford, the Institute for Neurobiology at Stanford, and at Harvard University and the Massachusetts Institute of Technology.
He is the author of over thirty books, including the bestsellers Brainstorms: The Emerging Science of the Human Mind and the best-selling Brainstorms books, Brainstorms II: How to Be Good at Thinking and Learning, Brainstorm III: How To Be Smart at Thinking, and Brainstorms IV: The Art of the Brain.
He was also an assistant professor at New York University and Harvard Medical schools.
He served as an advisor to the Presidents Science Advisory Board from 1997-2001.
His research focuses on the development and validation of computational models to describe the behavior of living systems and has led to some of the world’s most promising breakthroughs in neuroscience, neurobiology, and cognitive science.
He has received numerous awards for his work in this area including the John Templeton Medal, the James H. Baker Prize for Distinguished Contributions to Neuroscience, the MacArthur Foundation Scientific Achievement Award, the National Science Foundation Young Investigator Award, and several fellowships from the National Institute on Aging, the Robert Wood Johnson Foundation, the University College London, the American Association for the Advancement of Science, the Howard Hughes Medical Institute, the California Institute of Integral Science, and Stanford University.
Dr D’Amico is a member of two American Association of Neurologists (AAN) Committees on Science and Neurology, Neurobehavioral Rehabilitation and Clinical Trials.
He received the AAN Distinguished Service Award from the AANS in 2008.
Dr David L. Davis, M.D., is an associate professor of medicine at the Johns Hopkins University School of Medicine.
He joined the Johns Johns Hopkins School of Health in 2004.
Dr Davis has received over 20 patents, most recently for his groundbreaking new technique to rapidly and accurately detect and treat patients with complex disease.
His work on a novel form of genetic testing has led him to become a leader in the field of genetic therapeutics, which has made him a leading authority on the application of this technology in complex clinical situations.
He recently became the first professor of psychiatry to receive the American Psychiatric Association’s Outstanding Medical Scientist Award.
Dr Gabor Szabo is a professor of neurology and director of Johns Hopkins Brain Institute.
His clinical experience spans more than 25 years, and his research focuses